Skip to content
Screener

Prestige Consumer Healthcare PBH Women's Health — Total revenues

Other product segments

Gastrointestinal
$62.2M+7.6%
Dermatologicals
$33.2M+10.2%
Eye & Ear Care
$32.98M+2.1%
Pain Relief
$26.8M
Oral Care
$22.36M+3.0%
Cough, Cold & Allergy
$21.31M
Wellness, Sleep & Other
$14.33M

Similar metrics at other companies

UnitedHealth Group logo
UNHOptum Health — Total revenues
$24.11B-2.9%
TBR
TBRGFinancial Health — Total revenues
$53.27M-5.1%
Ziff Davis logo
ZDHealth & Wellness — Total revenues
$94.66M-4.8%
Organon logo
OGNOther Women's Health — Revenue
$46M+7.0%
Allstate logo
ALLAllstate Health and Benefits — Total revenues
$0-100%
PROG Holdings logo
PRGOther revenue — Total revenues
$39.4M+134%

Other financials

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%
EPS (diluted)$0.61-35.8%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total equity$1.9B+3.3%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation

See full
Market cap$2.58B-30.3%
Enterprise value$4.55B-1.2%
P/E15×-2.4×
P/S2.3×-1.0×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:15 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001295947-26-000042
(In thousands)Three Months Ended June 30, 2026 / North American OTCHealthcareThree Months Ended June 30, 2026 / International OTCHealthcareConsolidated
Dermatologicals30,6152,58033,195
Eye & Ear Care28,3394,63932,978
Gastrointestinal47,14115,06162,202
Oral Care18,4583,90022,358
Pain Relief26,22557726,802
Wellness, Sleep & Other12,5591,76814,327
Women's Health47,2415,30252,543
Total segment revenues$226,206$39,504$265,710

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Prestige Consumer Healthcare's women's health — total revenues?
Prestige Consumer Healthcare (PBH) reported women's health — total revenues of $52.54M in Q2 2026.
How has Prestige Consumer Healthcare's women's health — total revenues changed year-over-year?
Prestige Consumer Healthcare's women's health — total revenues decreased by 3.7% year-over-year, from $54.58M to $52.54M.
What is the long-term trend for Prestige Consumer Healthcare's women's health — total revenues?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's women's health — total revenues has grown at a -3.9% compound annual growth rate (CAGR), from $264.51M to $225.59M.
What does women's health — total revenues mean?
This metric represents the total gross revenue generated from the sale of products within the company's dedicated women's health portfolio. It captures the market demand and commercial performance of brands focused on feminine hygiene and related personal care categories. Tracking this revenue stream provides insight into the segment's contribution to overall corporate growth and its ability to maintain category leadership in specialized consumer health markets.

Ask your AI about Prestige Consumer Healthcare's women's health — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude